Amplifon’s most recent financial report suggests the giant retail hearing group is confident that its 2025 moves are producing the desired outcomes. It is good shape for the GN carve-up that, if unchallenged by competition regulators, will give the retail group a daunting verticality....
Continue reading at Audiology Worldnews
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is corporate financial and M&A news with no direct implications for clinical practice.
If regulators approve the Amplifon–GN Hearing retail acquisition, it would significantly concentrate ownership of hearing care retail networks, potentially affecting competition, pricing, and independent clinic dynamics across multiple markets.
- 01Amplifon posted its highest two-year organic growth in Q2, signalling strong post-pandemic retail hearing demand.
- 02Profitability acceleration was reported alongside the growth figures.
- 03Amplifon's planned acquisition of GN Hearing's retail assets is pending competition regulatory review.
- 04The deal, if approved, would further consolidate the global hearing retail market.
- 05No timeline for regulatory decision was specified in the report.
Amplifon achieved its highest two-year organic growth in Q2.
press releasepartially supportedAmplifon is experiencing profitability acceleration.
press releasepartially supportedAmplifon's acquisition of GN Hearing's retail assets is pending competition regulatory review.
press releasesupported
